NYSE:HI
NYSE:HIMachinery

Hillenbrand (HI): Is the Recent 25% 90-Day Climb Justified by Its Valuation?

Hillenbrand (HI) has quietly ground higher this past quarter, leaving some investors wondering what is driving the move and whether the current price still reflects a reasonable entry point. See our latest analysis for Hillenbrand. At around $31.70, the recent 90 day share price return of roughly 25 percent suggests sentiment has turned more constructive, even though the longer term total shareholder returns have been negative. If Hillenbrand has you rethinking where the next leg of...
NYSE:CL
NYSE:CLHousehold Products

Is Colgate-Palmolive’s Dividend Hike Amid AI Spend and Downgrade Altering The Investment Case For Colgate-Palmolive (CL)?

Earlier this month, Colgate-Palmolive’s board declared a quarterly cash dividend of US$0.52 per share, payable on February 13, 2026, to shareholders of record as of January 21, 2026. Around the same time, an Argus downgrade on profitability concerns contrasted with Colgate’s reaffirmed 2030 Strategy and stepped-up investments in AI, predictive analytics, and automation to support efficiency and brand strength. We’ll now examine how rising raw material costs and tariff headwinds highlighted...
NasdaqGS:LNT
NasdaqGS:LNTElectric Utilities

Assessing Alliant Energy’s (LNT) Valuation After a Year of Steady Share Price Gains

Alliant Energy (LNT) has quietly delivered a solid year, with the stock up roughly 16% over the past year and about 12% year to date, outpacing many defensive utilities. See our latest analysis for Alliant Energy. That rise has been driven more by a steady reset in expectations than any single headline, with a roughly 12 percent year to date share price return reinforcing a three year total shareholder return above 30 percent. This suggests momentum is quietly building as investors reassess...
OTCPK:NASB
OTCPK:NASBBanks

NASB Financial (NASB) Q4 EPS Beat Reinforces Bullish Margin Narrative Despite Long-Term Earnings Slide

NASB Financial’s latest FY 2025 fourth quarter update put fresh numbers on the table, with revenue at about $23.2 million and EPS of $1.12, setting the tone for how investors will read the year in review. The company has seen quarterly revenue move from $20.8 million and EPS of $0.84 in Q4 2024 to $23.2 million and $1.12 in Q4 2025, while trailing twelve month revenue has hovered in the mid to high $80 million range and EPS around the mid to high $3.00s. This leaves investors to focus on how...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Viking Therapeutics (VKTX): Assessing an Expensive Valuation After a Recent Pullback in the Share Price

Viking Therapeutics (VKTX) has been drifting lower this month after a powerful run over the past year, and that pullback is exactly what has traders asking whether the story still holds up. See our latest analysis for Viking Therapeutics. That recent slide, including a 1 month share price return of minus 10.35 percent and a year to date share price return of minus 16.67 percent, comes after a huge three year total shareholder return of 334.28 percent. This suggests momentum is cooling as...
NYSE:LB
NYSE:LBReal Estate

Is LandBridge (LB) Quietly Recasting Its Permian Story With Samsung-Backed Battery Storage Deals?

In December 2025, LandBridge Company LLC announced development agreements with subsidiaries of Samsung C&T Renewables, granting exclusive options to lease acreage for two Battery Energy Storage System projects in Pecos and Loving counties, Texas, with a combined planned capacity of 350 MW and potential commercial operation by year-end 2028. These will be the first battery storage projects on LandBridge’s land, highlighting how the company is beginning to use its Permian footprint for...
NYSE:STZ
NYSE:STZBeverage

Does Constellation Brands’ 37% Slide Create an Opportunity for Investors in 2025?

If you are wondering whether Constellation Brands is finally cheap enough to consider or still a value trap in disguise, this breakdown will help you assess whether the current price matches the business behind the ticker. The stock has fallen 37.2% over the past year and is down 36.7% over three years, even after a recent 6.7% bounce in the last 30 days that has some investors asking if the selling has gone too far. Recent headlines have focused on shifting consumer demand in the premium...
NasdaqGS:PNFP
NasdaqGS:PNFPBanks

Has Pinnacle Financial Partners Price Jump Left Further Upside After Recent Regional Bank Rebound?

Wondering if Pinnacle Financial Partners at around $100 a share is still a smart buy or if the easy money has already been made? Let us unpack what the current price might be telling you about its real value. The stock has crept up about 0.2% over the last week and jumped 18.6% in the past month, even though it is still down 11.8% year to date and 8.9% over the last year. Zooming out further, it is up 40.9% over three years and 62.1% over five, so there is clearly a longer term growth story...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Does RadNet Still Offer Value After Its Multi Year Surge and AI Imaging Buzz

If you are wondering whether RadNet is still good value after its big multi year run up, you are not alone. This article will walk through what the current price really implies. After rising roughly 268% over 3 years and 286% over 5 years, the stock has cooled off recently with a 7.7% drop in the last week, 7.6% over the last month, and only a modest 1.5% gain year to date. That pullback comes as investors digest a mix of headlines around AI powered imaging, outpatient care demand, and...
NYSE:TRV
NYSE:TRVInsurance

Has Travelers Stock Run Too Far After Its Strong Multi Year Rally?

Wondering if Travelers Companies is still a smart buy after its big run, or if you would be overpaying at today’s levels? This breakdown will help you put a number on what the stock might really be worth. The share price recently closed around $291.27, after climbing 4.6% over the last week, 2.4% over the past month, and delivering a strong 25.4% gain over the last year that builds on a 62.8% three year and 133.4% five year run. Behind those moves, investors have been digesting a steady...
NYSE:ABM
NYSE:ABMCommercial Services

ABM Industries (ABM) Margin Compression to 1.3% Fuels Bearish Narrative on Earnings Quality

ABM Industries (ABM) has just posted its FY 2025 third quarter results with revenue of about $2.2 billion and EPS of $0.67, setting the tone for a year where margins and one off items are firmly in focus for investors. Over the past few quarters, the company has seen revenue move from $2.02 billion in Q2 FY 2024 to $2.11 billion in Q2 FY 2025 and then to $2.22 billion in Q3 FY 2025, while quarterly EPS has tracked in a tight band between roughly $0.67 and $0.70, pointing to stable...
NYSE:GS
NYSE:GSCapital Markets

Can Goldman Sachs Still Reward Investors After Its 52% Surge in 2025?

If you are wondering whether Goldman Sachs Group is still worth buying after this huge run, you are not alone. This is exactly the kind of stock where valuation really matters. The share price has climbed an impressive 51.7% year to date and 61.8% over the last year, even after a recent 1.9% pullback over the past week and a 12.5% gain in the last 30 days. This puts its longer term 3 year and 5 year returns at 168.6% and 283.1% respectively. Investors have been reacting to a mix of macro and...
NasdaqGS:RELY
NasdaqGS:RELYDiversified Financial

Remitly (RELY) Valuation After Investor Day’s Updated Long-Term Growth and Margin Expansion Outlook

Remitly Global (RELY) just refreshed its long term roadmap at Investor Day, projecting high teens revenue growth in 2026 and targeting up to 3 billion dollars in annual revenue by 2028. See our latest analysis for Remitly Global. The upbeat long term roadmap seems to be stabilising sentiment, with the share price at 14.48 dollars after a recent 1 month share price return of 14.9 percent. The year to date share price return is still down sharply, but the 3 year total shareholder return remains...
NYSE:VTOL
NYSE:VTOLEnergy Services

Assessing Bristow Group’s valuation as it launches UK electric air-taxi routes with Vertical Aerospace and Skyports

Bristow Group (NYSE:VTOL) just moved from traditional helicopter ops into next generation urban mobility, teaming up with Vertical Aerospace and Skyports to develop electric air taxi routes linking Canary Wharf with Heathrow, Gatwick and other key hubs. See our latest analysis for Bristow Group. The market has taken a breather despite this futuristic pivot, with a 30 day share price return of minus 6.5 percent and a year to date share price gain of 2.8 percent. However, the three year total...
NYSE:NRGV
NYSE:NRGVElectrical

Energy Vault (NRGV) Is Up 11.1% After $145M Shelf Filing And Swiss FlexGrid Launch - Has The Bull Case Changed?

Earlier in December 2025, Energy Vault Holdings, Inc. filed and then closed a US$144.98 million shelf registration for 33,251,333 common shares while also entering the Swiss market with FlexGrid, a new 2–25 MW B-VAULT battery storage configuration for commercial, industrial, and small-utility customers. This Swiss launch, backed by agreements with Schindler Group and Energie Wettingen AG within CKW’s advanced Flexpool network, expands Energy Vault’s European footprint and adds to a B-VAULT...
NYSE:COHR
NYSE:COHRElectronic

Is It Too Late To Consider Coherent After Its 406.5% Three Year Surge?

If you are wondering whether Coherent is still good value after its big run, you are not alone. This is exactly the kind of stock where the story and the numbers do not always line up neatly. The share price has been volatile lately, dropping 13.7% over the last week, but still up 22.6% over 30 days, 69.4% year to date, and 75.1% over the past year, with a 406.5% gain over three years. Those moves have been shaped by a steady stream of headlines around demand for photonics and laser...
NYSE:MC
NYSE:MCCapital Markets

Has the Rally in Moelis Shares Already Gone Too Far?

Wondering if Moelis is still a smart buy at current levels, or if most of the upside is already priced in? Let’s walk through what the recent moves and fundamentals are really telling us about its value. The stock has been choppy in the short term, down 1.7% over the last week, but it is still up 14.5% over the past month and almost doubled over 3 and 5 years, with gains of 95.5% and 97.5% respectively. Those gains have been driven by Moelis positioning itself as a go to advisor on big...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Did Enphase’s (ENPH) Expanded Safe Harbor Deal Rewire Its U.S. Solar Incentive Strategy?

Enphase Energy has recently expanded a safe harbor agreement with a leading solar financing company, a move expected to generate about US$55.0 million in revenue across late 2025 and early 2026 while supporting tax credit eligibility and deployments of its U.S.-manufactured IQ8 microinverters. By tying third-party ownership financing more tightly to domestically produced hardware, Enphase is positioning its ecosystem to benefit from U.S. clean energy incentives and policy-driven demand for...
NYSE:CWAN
NYSE:CWANSoftware

Clearwater Analytics (CWAN): Reassessing Valuation After Recent Share Price Rebound

Clearwater Analytics Holdings (CWAN) has quietly outperformed the broader market over the past month, with the stock up about 9% and roughly 12% over the past 3 months despite a weaker year to date. See our latest analysis for Clearwater Analytics Holdings. That recent strength sits against a tougher backdrop, with the year to date share price return still negative while the 3 year total shareholder return remains positive. This suggests momentum in Clearwater Analytics Holdings is only now...
NYSE:FNF
NYSE:FNFInsurance

How Expectations for a Higher ROE and Lower Payout Ratio Will Impact Fidelity National Financial (FNF) Investors

In the past week, Fidelity National Financial drew attention as investors reacted to its 14% return on equity, slightly above the 13% industry average, despite multi-year earnings declines. Expectations that the company’s payout ratio could fall to 30% and potentially lift future ROE to 18% are shaping a more optimistic view of its earnings power. We’ll now examine how expectations for a higher future ROE may influence Fidelity National Financial’s broader investment narrative and risk...
NYSE:MGY
NYSE:MGYOil and Gas

Assessing Magnolia Oil & Gas’s Valuation After Mizuho Upgrade on Inventory Quality and Free Cash Flow Upside

Why Magnolia Oil & Gas Is Back on Investors Radar Mizuho just upgraded Magnolia Oil & Gas (MGY) after taking a fresh look at its low breakeven wells, conservative balance sheet, and steady cash returns, arguing the stock now trades at an appealing free cash flow discount. See our latest analysis for Magnolia Oil & Gas. That upgrade comes after a choppy stretch, with the share price down on a 3 month and year to date basis even as the 5 year total shareholder return of 221.47 percent indicates...
NYSE:OMC
NYSE:OMCMedia

Omnicom Group (OMC): Is the Recent Share Price Rebound Leaving the Stock Undervalued?

Omnicom Group (OMC) has been quietly grinding higher, with the stock up about 3 % in a day, 7 % over the week, and roughly 13 % in the past month. See our latest analysis for Omnicom Group. Despite that recent momentum, with a 30 day share price return of 13.24 %, Omnicom Group is still slightly negative on a year to date share price basis, while its five year total shareholder return of 59.18 % points to solid long term value creation. If Omnicom Group’s move has you rethinking where growth...
NasdaqGS:FIVE
NasdaqGS:FIVESpecialty Retail

Does Five Below’s Upgraded 2025 Outlook And Buyback Completion Shift The Bull Case For FIVE?

In early December 2025, Five Below reported third-quarter sales of US$1,038.29 million and net income of US$36.51 million, and raised its full-year 2025 outlook to net sales of US$4.62–4.65 billion and net income of US$306–316 million while confirming it had completed a US$69.46 million share repurchase program. The upgraded guidance, underpinned by higher comparable sales assumptions and continued store openings, highlights how Five Below’s merchandising reset and value-focused format are...
NasdaqGM:CSTL
NasdaqGM:CSTLHealthcare

Castle Biosciences (CSTL): Assessing Valuation After Expert Consensus Endorses DecisionDx-Melanoma Test

A new expert consensus paper backing Castle Biosciences (CSTL) DecisionDx Melanoma test has pushed the stock higher, as investors weigh what wider physician adoption could mean for growth and valuation. See our latest analysis for Castle Biosciences. The expert backing for DecisionDx Melanoma comes on top of an already powerful move in the stock, with a roughly 69 percent three-month share price return and a nearly 50 percent one-year total shareholder return. This suggests momentum is...